Calcium-sensing receptor autoantibodies in primary hyperparathyroidism

Area of Science:

• Endocrinology
• Immunology
• Genetics

Background:

• Primary hyperparathyroidism (PHPT) mechanisms are not fully understood, as CaSR gene mutations are not found in all patients.
• An autoimmune basis for PHPT is hypothesized, with autoantibodies against the CaSR detected in some individuals.
• This study aimed to assess CaSR autoantibody prevalence in a large PHPT cohort.

Purpose of the Study:

• To investigate the presence and prevalence of autoantibodies against the calcium-sensing receptor (CaSR) in patients with primary hyperparathyroidism.
• To explore potential correlations between CaSR autoantibodies and clinical/histological features of PHPT.

Main Methods:

• Utilized immunoblotting with recombinant human CaSR extracellular domain and immunofluorescence with parathyroid adenoma tissue.
• Tested 75 patients diagnosed with primary hyperparathyroidism for CaSR autoantibodies.

Main Results:

• CaSR autoantibodies were detected in 5 out of 75 (6.7%) PHPT patients.
• No significant differences in post-operative parathyroid hormone (PTH) levels were observed between antibody-positive and antibody-negative groups.
• Histological analysis revealed no increased lymphocytic infiltration in parathyroid tissue of patients with CaSR autoantibodies.

Conclusions:

• The study confirms the presence of CaSR autoantibodies in a subset of primary hyperparathyroidism patients.
• The precise pathophysiological significance of CaSR autoantibodies in the development and progression of PHPT remains to be determined and warrants further research.